Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05911568 · ClinicalTrials.gov registry record
Treatment With Endovascular Intervention for STroke Patients With Existing Disability
A clinical trial of Stroke and Stroke, Ischemic, sponsored by University of Cincinnati.
- Recruiting
- Registry status
- 1,060
- Enrollment target
- 19
- Study locations
NCT05911568: Recruiting study of Stroke and Stroke, Ischemic, sponsored by University of Cincinnati.
NCT05911568 is a study of Stroke and Stroke, Ischemic that is actively recruiting participants, run by University of Cincinnati. The registered enrollment target is 1,060 participants, below the 12,014-participant average among 454 other Stroke trials with a reported enrollment target (91% lower). The trial reports 19 study locations across 15 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05911568, a study of Stroke and Stroke, Ischemic, is actively recruiting participants, sponsored by University of Cincinnati.
- RECRUITING
- Registry status
- 1,060 participants
- Enrollment target
- 19
- Study locations
Study Summary
TESTED will compare the risks and benefits of endovascular thrombectomy (EVT) to medical management (no EVT) in ischemic stroke patients who have a blockage in one of the large blood vessels in the brain and have a moderate-to-severe disability prior to their stroke.
Primary Outcome
Score of 0-3, 4, 5 or 6 on the modified Rankin Scale (mRS) (Note: mRS range: 0 (no residual symptoms) to 6 (death)
Conditions Studied
Interventions
- OTHER Medical Management
- PROCEDURE Endovascular Stroke Treatment
Study Locations (19)
California
- Kaiser Permanente Los Angeles Medical Center - Los Angeles
- University of California at Los Angeles - Los Angeles
Connecticut
- Hartford Health Hospital - Hartford
- Yale University - New Haven
New York
- Icahn School of Medicine at Mount Sinai - New York
- Columbia University - New York
Tennessee
- Baptist Memorial Hospital - Memphis
- Vanderbilt University Medical Center - Nashville
Arizona
- HonorHealth - Phoenix
Colorado
- Swedish Medical Center - Englewood
Florida
- University of Miami - Miami
Georgia
- Emory University - Atlanta
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,060 participants |
| Start Date | 2023-11-16 |
| Est. Completion | 2028-04-15 |
What NCT05911568 shows while recruiting
NCT05911568 is an observational study that tracks outcomes without assigning an intervention. Its 1,060 participants enrollment target places it among the larger protocols in the corpus, below the 12,014-participant average among 454 other Stroke trials with a reported enrollment target (91% lower).
The record links to 3 conditions, with Stroke appearing as the primary indexed condition, and to 2 interventions - of which Medical Management is the first listed.
NCT05911568 lists 19 locations in 15 states (California, Connecticut, New York).
Frequently Asked Questions
What is clinical trial NCT05911568 about?
NCT05911568 is a clinical study titled "Treatment With Endovascular Intervention for STroke Patients With Existing Disability". TESTED will compare the risks and benefits of endovascular thrombectomy (EVT) to medical management (no EVT) in ischemic stroke patients who have a blockage in one of the large blood vessels in the brain and have a moderate-to-severe disability prior to their stroke.
What is the current status of trial NCT05911568?
This trial is currently recruiting. The enrollment target is 1,060 participants. The study started on 2023-11-16. Estimated completion is 2028-04-15.
What conditions does trial NCT05911568 study?
This clinical trial studies the following conditions: Stroke, Stroke, Ischemic, Stroke, Acute.
What interventions are being tested in trial NCT05911568?
The interventions under investigation include: Medical Management (OTHER), Endovascular Stroke Treatment (PROCEDURE).
Who is sponsoring clinical trial NCT05911568?
This trial is sponsored by University of Cincinnati, which has 245 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05911568 being conducted?
This trial has 19 study locations across Arizona, California, Colorado, Connecticut, Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Stroke
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05911568's enrollment target sits among peer trials
1,060 36th of 454 higher than 419 of 454 other Stroke trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Stroke trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
The SLEEPR Study: SLEep Effects on Post-stroke Rehabilitation
RECRUITING
-
Tracking a Tactile Signal Along the Nervous System
RECRUITING · NA
-
Transcranial Direct Current Stimulation (tDCS) With Verb Network Strengthening Treatment (VNeST) in Chronic Aphasia
RECRUITING · NA
-
Genetic and Environmental Risk Factors for Hemorrhagic Stroke
RECRUITING
-
Strategy Training for Individuals With Unilateral Neglect
RECRUITING · NA
-
Weight Loss and ExeRcise
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05520762 · 1,060 participants · NA
Hospital Airway Resuscitation Trial
- NCT07140172 · 1,060 participants · NA
Axillary Radiotherapy or Axillary Lymph Node Dissection in Patients With Clinically Node- Positive Breast Cancer Undergoing Upfront Tailored Axillary Surgery
- NCT05125302 · 1,059 participants · Phase 3
Study to Assess Adverse Events and Disease Activity of Oral Ubrogepant Tablets for the Acute Treatment of Migraine in Children and Adolescents (Ages 6-17)
- NCT03588286 · 1,058 participants · NA
Programmed Ventricular Stimulation to Risk Stratify for Early Cardioverter-Defibrillator (ICD) Implantation to Prevent Tachyarrhythmias Following Acute Myocardial Infarction (PROTECT-ICD)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI